Click on the link below to access the 2015/2016 Annual Report (Audited) covering the Company’s financial position and the next steps for the Company:
The 2015/2016 Annual Report provides IMPORTANT information regarding the Company's core business, recent activities and current status for Shareholders and other interested parties.
If funding for the Company to continue it's core business is not received prior to the 2016 AGM commencing, Shareholders will be asked to vote on placing BioSyngas into Members Voluntary Liquidation (solvent).